Alprazolam


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000647 Amnesia PMID:3358644; PMID:9467187
MESH:D000799 Angioedema PMID:16987489
MESH:D000860 Hypoxia PMID:11815692
MESH:D001008 Anxiety Disorders PMID:12388988; PMID:12561965; PMID:16143734; PMID:2307974; PMID:2335496; PMID:8666573
MESH:D001259 Ataxia PMID:3358644; PMID:7802851
MESH:D001281 Atrial Fibrillation PMID:10389047
MESH:D001342 Autonomic Nervous System Diseases PMID:10389047
MESH:D001523 Mental Disorders PMID:3421354
MESH:D001714 Bipolar Disorder PMID:3358644; PMID:3680608; PMID:3818553; PMID:8887708
MESH:D001919 Bradycardia PMID:10464538
MESH:D003072 Cognition Disorders PMID:11815692
MESH:D003128 Coma PMID:10464538; PMID:8967683
MESH:D003693 Delirium PMID:11815692; PMID:1863727; PMID:6141159; PMID:9617514
MESH:D003866 Depressive Disorder PMID:2764184; PMID:3358644; PMID:3578580; PMID:7802851; PMID:8666573
MESH:D004211 Disseminated Intravascular Coagulation PMID:10464538
MESH:D004244 Dizziness PMID:18635690; PMID:2307974; PMID:2873131
MESH:D004775 Enuresis PMID:7802851
MESH:D005221 Fatigue PMID:18635690; PMID:3358644
MESH:D005334 Fever PMID:11815692
MESH:D006212 Hallucinations PMID:12923827; PMID:2397358
MESH:D006948 Hyperkinesis PMID:7197658
MESH:D006966 Hyperprolactinemia PMID:8803653
MESH:D006970 Disorders of Excessive Somnolence PMID:17097811; PMID:18635690; PMID:2858187
MESH:D007022 Hypotension PMID:10389047
MESH:D007035 Hypothermia PMID:10464538
MESH:D007565 Jaundice PMID:2869702
MESH:D007859 Learning Disabilities PMID:12388988
MESH:D008569 Memory Disorders PMID:12388988; PMID:14644903; PMID:7802851
MESH:D009069 Movement Disorders PMID:19519270
MESH:D009336 Necrosis PMID:19490937
MESH:D009459 Neuroleptic Malignant Syndrome PMID:16720068
MESH:D010259 Paranoid Disorders PMID:1742638; PMID:2040718; PMID:2397358
MESH:D010554 Personality Disorders PMID:12388988; PMID:2912273
MESH:D011183 Postoperative Complications PMID:1863727
MESH:D011297 Prenatal Exposure Delayed Effects PMID:12388988; PMID:12561965
MESH:D011618 Psychotic Disorders PMID:2300914; PMID:2307974
MESH:D012640 Seizures PMID:12525317; PMID:2107764; PMID:2300914; PMID:2307974; PMID:6141159
MESH:D012893 Sleep Wake Disorders PMID:2307974; PMID:2335496
MESH:D013035 Spasm PMID:2307974
MESH:D013064 Speech Disorders PMID:19519270; PMID:3358644
MESH:D013226 Status Epilepticus PMID:14644903
MESH:D013262 Stevens-Johnson Syndrome PMID:25811541
MESH:D013375 Substance Withdrawal Syndrome PMID:12525317; PMID:12701671; PMID:14644903; PMID:1559372; PMID:1742638; PMID:1863727; PMID:2300914; PMID:2307974; PMID:2335496; PMID:2397358; PMID:2637682; PMID:3806075; PMID:3826428; PMID:6141159; PMID:9617514; PMID:9884109
MESH:D013610 Tachycardia PMID:10389047; PMID:2307974
MESH:D014652 Vascular Diseases PMID:10464538
MESH:D015431 Weight Loss PMID:2869702; PMID:7802851
MESH:D015812 Glaucoma, Angle-Closure PMID:10965252
MESH:D016584 Panic Disorder PMID:11841142; PMID:2307974
MESH:D019966 Substance-Related Disorders PMID:3258735
MESH:D020018 Sexual Dysfunctions, Psychological PMID:3348461
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:2869702; PMID:3358644
MESH:D056784 Leukoencephalopathies PMID:11815692

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.